2020
DOI: 10.1002/mc.23166
|View full text |Cite
|
Sign up to set email alerts
|

A functional variant in TNXB promoter associates with the risk of esophageal squamous‐cell carcinoma

Abstract: Our previous study identified a tag single‐nucleotide polymorphism (SNP) rs204900 in TNXB associated with risk of esophageal squamous‐cell carcinoma (ESCC) in the Chinese population. However, the functional role of TNXB and causal variants had not been interrogated in that study. In the present study, we explored the effects of TNXB expression in the development of ESCC and searched for functional variants in this gene. We found TNXB was downregulated in ESCC tumors. Using small interfering RNAs and CRISPR–Cas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 37 publications
0
6
0
Order By: Relevance
“…On the other hand, there have been several reports of TNX expression being downregulated during tumor progression in astrocytomas (33), cutaneous melanoma (34), and neurofibromatosis type 1 (35), findings that are mostly opposite to those for TNC. Intriguingly, it has also been reported that TNX has a tumor suppressor role in cervical cancer via LINC01305 expression which modulates TNX expression (22), esophageal squamous-cell carcinoma (36), and lung cancer via LINC01305 expression (23) and that TNX is downregulated in these tumors. In agreement with the tumor suppressor role of TNX in cancer progression, TNX-deficient mice with grafted melanoma cells exhibited promotion of tumor invasion and metastasis because of increased activities of matrix metalloproteinases (MMPs) (37,38).…”
Section: Tnx Expression In Cancersmentioning
confidence: 99%
“…On the other hand, there have been several reports of TNX expression being downregulated during tumor progression in astrocytomas (33), cutaneous melanoma (34), and neurofibromatosis type 1 (35), findings that are mostly opposite to those for TNC. Intriguingly, it has also been reported that TNX has a tumor suppressor role in cervical cancer via LINC01305 expression which modulates TNX expression (22), esophageal squamous-cell carcinoma (36), and lung cancer via LINC01305 expression (23) and that TNX is downregulated in these tumors. In agreement with the tumor suppressor role of TNX in cancer progression, TNX-deficient mice with grafted melanoma cells exhibited promotion of tumor invasion and metastasis because of increased activities of matrix metalloproteinases (MMPs) (37,38).…”
Section: Tnx Expression In Cancersmentioning
confidence: 99%
“…In addition, silencing of long non-coding RNA (LncRNA) LINC01305 inhibited the progression of lung cancer by activating the TNX-mediated phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway ( Yan et al, 2020 ). Moreover, it has been revealed that a functional variant in the TNXB promoter is associated with risk of esophageal squamous-cell carcinoma (ESCC) in the Chinese population, leading to the expression of TNXB being downregulated in ESCC tissues ( Chang et al, 2018 ; Yang et al, 2020 ). Knockout of TNXB significantly increased cell proliferation of ESCC cells ( Yang et al, 2020 ).…”
Section: Tnx With Tumor Suppressive Functionmentioning
confidence: 99%
“…Moreover, it has been revealed that a functional variant in the TNXB promoter is associated with risk of esophageal squamous-cell carcinoma (ESCC) in the Chinese population, leading to the expression of TNXB being downregulated in ESCC tissues ( Chang et al, 2018 ; Yang et al, 2020 ). Knockout of TNXB significantly increased cell proliferation of ESCC cells ( Yang et al, 2020 ). These results suggest that TNX has a tumor suppressor role.…”
Section: Tnx With Tumor Suppressive Functionmentioning
confidence: 99%
“…Further analysis revealed that the risk score was independent of other clinical information in the ESCA prognosis model. TNXB knockout has been shown to promote the proliferation of esophageal carcinoma cells, suggesting that TNXB plays a tumor-suppressive role by inhibiting the proliferation of esophageal carcinoma cells [43]. STK31 has been implicated in promoting the progression of pancreatic cancer by enhancing cell proliferation, migration, and invasion.…”
Section: Rt-qpcr Validation For the Expression Of Pla2g2f Hhip Tnxb A...mentioning
confidence: 99%